Sept. 26, 2023—Streck announced that its MDx-Chex for BC-GP and MDx-Chex for BC-GN quality controls, designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive (BC-GP) and Gram-Negative (BC-GN) tests for blood stream infection and sepsis, have been granted FDA clearance for use in diagnostic procedures.
Read More »Streck introduces viral extraction kit
July 2022—Streck, in partnership with Ceres Nanosciences, announced the availability of its viral extraction kit for clinical samples containing SARS-CoV-2 and influenza A.
Read More »Streck introduces viral extraction kit
June 28, 2022—Streck, in partnership with Ceres Nanosciences, announced the availability of its viral extraction kit for clinical samples containing SARS-CoV-2 and influenza A.
Read More »FDA clears Streck MDx-Chex for BCID2
March 2022—Streck’s MDx-Chex for BCID2, a quality control designed to meet the standards for verifying the performance of the BioFire BCID2 panel assay for sepsis, has been granted FDA clearance for in vitro diagnostics use.
Read More »FDA clears Streck MDx-Chex for BCID2
Jan. 31, 2022—Streck’s MDx-Chex for BCID2, a quality control designed to meet the standards for verifying the performance of the BioFire BCID2 panel assay for sepsis, has been granted FDA clearance for in vitro diagnostics use.
Read More »Streck launches QC for sepsis
January 2022—Streck announced the availability of its MDx-Chex for BCID2 quality control, designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis.
Read More »Streck launches QC for sepsis
Dec. 24, 2021—Streck announced the availability of its MDx-Chex for BCID2 quality control, designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis.
Read More »Streck launches rapid, modular qPCR instrument
January 2021—Streck has launched its Zulu RT, a rapid, modular qPCR instrument. The instrument consists of four independent thermal modules. A user can operate any combination of modules—one module for a small sample set, leaving other modules for other users, or up to four modules simultaneously for a large sample set. It can perform a 40-cycle, six-channel real-time PCR in less than 20 minutes.
Read More »Streck CE-marked AMR surveillance kits
April 2020—Streck released CE-marked ARM-D kits for the OXA, MCR, and TEM/SHV/GES gene families.
Read More »Biodesix partners with Streck
March 2020—Biodesix and Streck announced a regulatory cooperation agreement that will further enable the companies to pursue FDA approval for diagnostic testing services and specimen collection products.
Read More »Streck releases CE-marked AMR surveillance kits
Feb. 25, 2020—Streck released CE-marked ARM-D kits for OXA, MCR, and TEM/SHV/GES gene families.
Read More »Streck antibiotic resistance detection kits, blood collection tube
September 2019—Streck introduced three antibiotic resistance detection kits and its blood collection tube at the AACC Annual Scientific Meeting and Clinical Lab Expo, Aug. 6-–8, in Anaheim, Calif.
Read More »Streck adds instrument to linearity control
February 2019—Streck Retic-Chex Linearity for BC is now assayed for the Beckman Coulter UniCel DxH 900 analyzer. Retic-Chex Linearity for BC is designed to establish the reportable range and linearity of analyzers that report the reticulocyte parameter.
Read More »Streck launches sed-rate analyzer
July 2018—Streck and Diesse Diagnostica Senese have introduced the Cube 30 Touch, an automated instrument for high-volume erythrocyte sedimentation rate testing in EDTA tubes.
Read More »Streck, Orgentec distribution agreement, 12/17
December 2017—Streck and Orgentec Sasu, a distributor in France that specializes in the in vitro diagnosis of autoimmunity, infectious diseases, molecular biology, internal/external quality control, biochemistry, and sedimentation rate, have signed an exclusive distribution agreement for Streck’s cell stabilization and molecular products.
Read More »Streck distribution agreements, 9/17
September 2017—Streck and Inter Medico, a privately owned Canadian distributor of medical diagnostic and research-related products, have signed a distribution agreement for Streck’s cell stabilization and molecular products. Inter Medico will have exclusive distribution rights in Canada to those Streck products.
Read More »Improved urinalysis control, 8/17
August 2017—Streck UA-Cellular Complete, a comprehensive cellular and chemistry analyte urinalysis control, is an integrated urinalysis control for the Siemens Clinitek Atlas/Sysmex UF-1000i and Arkray Aution Hybrid AU-4050 integrated systems. UA-Cellular Complete features true cellular components (no latex or other synthetic material) and provides three concentrations of combined urinalysis control to represent the various patient sample scenarios.
Read More »Streck distribution agreements, 7/17
July 2017—Streck has signed distribution agreements with Anopoli Biomedical Systems, an Austrian distributor of life sciences, molecular diagnostics, and microarray products, and with Ngaio Diagnostics,
Read More »Streck signs distribution agreements, 5/17
May 2017—Streck and GenomePrecision Technology, an integrated molecular diagnostics distributor in China, have signed a distribution agreement for Streck’s cell stabilization, molecular, urinalysis, and flow cytometry products.
Read More »Mini-Cube compatible with pediatric tubes, 4/17
April 2017—The Diesse Mini-Cube automated sed-rate instrument is now compatible with 500 µL patient samples in BD Microtainer tubes with K2 EDTA. The Mini-Cube also analyzes standard 13 × 75 mm K2 EDTA tubes with a patient sample fill volume range of 2.0 mL to 4.0 mL.
Read More »Antibiotic resistance monitoring and detection kitm, 4/17
March 2017—Streck’s CE-marked antibiotic resistance monitoring and detection (ARM-D) kits are now available. The Streck ARM-D kits, AmpC and β-lactamase, are multiplex real-time PCR reagents for the detection of more than 450 β-lactamase gene targets.
Read More »Streck assay added to Mindray instrument, 3/17
March 2017—Streck’s Para 12 Extend, a hematology control with three distinct populations of lymphocytes, mononuclears, and granulocytes, is now assayed for the Mindray BC-3600. Varying percentages are also offered in the low abnormal, normal, and high abnormal levels to test the accuracy and precision of the reported white cell populations.
Read More »Streck adds Makler to sperm count assays, 2/17
February 2017—Streck’s Sperm-Chex and Sperm-Chex Post VC, both with stabilized sperm cells, are now assayed for the Makler Counting Chamber. Sperm-Chex has two clinically significant levels of control to simulate the sperm cell concentration that technologists encounter in patient samples. It has the same chamber loading and optical characteristics as a patient sample. Sperm-Chex verifies the sperm analysis process and tests the technologist’s proficiency in sperm cell quantification and qualification.
Read More »Streck signs distribution agreement, 10/16
October 2016—Streck and Diesse Diagnostica Senese S.p.A., an Italian manufacturer of in vitro diagnostic systems, are introducing the Diesse Mini-Cube, an automated instrument for erythrocyte sedimentation rate testing in EDTA tubes. Streck will be the exclusive distributor of the Mini-Cube in the United States and Canada.
Read More »Streck supply agreements, 9/16
September 2016—Streck and Biodesix, a molecular diagnostics company that develops blood-based tests in oncology, have signed an agreement to make Streck the exclusive supplier of DNA and RNA tubes for Biodesix.
Read More »Blood collection device, 8/16
August 2016—Streck’s Cell-Free DNA BCT, for the collection and preservation of whole blood samples, is available as a 2.0 mL draw tube. The formaldehyde-free preservative reagent contained in Cell-Free DNA BCT inhibits nuclease-mediated degradation of cf-DNA and stabilizes nucleated blood cells, which prevents the release of cellular genomic DNA. Samples are stable for up to 14 days at temperatures between 6°–37°C, allowing convenient sample collection, transport, and storage.
Read More »Streck, Sysmex sign agreement, 5/16
May 2016—Streck and Sysmex Inostics, a subsidiary of Sysmex Corp., have announced that Sysmex has signed a worldwide supply and distribution agreement with Streck.
Read More »A1c-Cellular assayed for Ortho Vitros, 4/16
April 2016—Streck’s A1c-Cellular is now assayed for the Ortho-Clinical Diagnostics Vitros 4600. A1c-Cellular is an HbA1c control with intact red blood cells and tests the entire HbA1c procedure, including the lysing of the red blood cell.
Read More »Sperm count control products, 11/15
November 2015—Streck has acquired Fertility Solutions’ sperm count and post-vasectomy quality control products. The sperm count controls for fertility diagnosis have been renamed Sperm-Chex and Sperm-Chex Post VC.
Read More »Urine preservative product, 10/15
Lab Sensor Solutions will partner with MarketLab to distribute T-Tracks, which tracks, in real time, the temperature and location of clinical samples in transit, preventing laboratory specimen spoilage and loss and ensuring regulatory compliance. T-Tracks data are delivered to lab personnel’s desktops, laptops, and mobile devices.
Read More »Flow cytometry control, 9/15
New products featured by Streck this year included CD-Chex CD103 Plus, a flow cytometry control. It includes CD103, CD30, CD38, CD56, CD138, and cytoplasmic lambda in a single control and provides reference values for CD38. The control includes rare leukemia and lymphoma CD markers that are absent in normal whole blood.
Read More »Linearity control assay, 7/15
July 2015—Streck’s Calibration Verification Assessment (CVA) is now assayed for the Horiba ABX Micros 60 instrument. CVA is an assayed linearity control kit used to determine the patient reportable range of three-part and five-part hematology instruments.
Read More »Flow cytometry control, 6/15
June 2015—Streck has introduced CD-Chex TdT Plus, a flow cytometry control assayed for TdT, CD1a, CD34, and cCD3. CD-Chex TdT Plus can be used as quality control material for evaluating intracellular and surface antigens including CD1a, CD2, CD4, CD5, CD7, CD8, CD34, cytoplasmic CD3, and nuclear TdT (terminal deoxynucleotidyl transferase).
Read More »Streck adds instruments to body fluid control assay, 3/15
March 2014—Streck’s Cell-Chex Auto is now assayed for Siemens Healthcare Diagnostics’ Advia 120/2120/2120i instrument system. Cell-Chex Auto is a three-level spinal and body fluid control for evaluating the accuracy and precision of hematology instruments that measure blood cell counts in patient body fluid samples.
Read More »Instrument added to Streck assay, 2/15
February 2014—Streck’s A1c-Cellular, a whole red blood cell A1c control with intact red blood cells, is now assayed for the Abbott Architect Integrated ci Systems. A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell.
Read More »Instrumentation added to assays, 12/14
December 2014—Streck’s A1c-Cellular Linearity, an HbA1c linearity/calibration verification material with intact red blood cells, is now assayed for the Trinity Biotech Premier Hb9210 and Ultra2 instruments. A1c-Cellular Linearity is a five-level assayed linearity material used to assess instrument accuracy and verify the patient reportable range of the HbA1c parameter.
Read More »Flow cytometry controls, 8/14
August 2014—Streck added markers to CD-Chex CD117 Plus, a commercially available positive procedural control for CD117, and now CD25 and CD71. CD-Chex 117 Plus eliminates the need for laboratories to hold and validate patient samples to use as a control for CD117, CD25, and CD71.
Read More »Combined urinalysis control, 6/14
June 2014—Streck introduced UA-Cellular Complete, a urinalysis control with both chemistry analytes and cellular components to more closely mimic a patient sample.
Read More »HbA1c control, 9/13
Streck’s A1c-Cellular Linearity, an HbA1c linearity/calibration verification material with intact red blood cells, is now assayed for Roche Diagnostics’ Cobas c 311. It is a five-level assayed linearity material used to assess instrument accuracy and verify the patient reportable range of the HbA1c parameter. The product does not require reconstitution, which reduces the potential for human errors and saves time. ...
Read More »Hematology control, 8/13:89
Streck’s Retic-Chex Linearity, designed to establish the patient reticulocyte reportable range and linearity, is now assayed for the Sysmex XN series (XN-10 and XN-20) hematology instruments.
Read More »Flow cytometry control for CD117, 6/13:96
Streck’s CD-Chex CD117 is a flow cytometry control for CD117. The control eliminates the need for laboratories to hold and validate patient samples to use as a control for CD117, saving time and money. CD-Chex CD117 is designed to represent abnormal peripheral blood leukocytes similar to a hematolymphoid neoplastic patient sample. The product has surface CD117 that is detectable with fluorescent monoclonal antibodies by flow cytometry. The CD117 positive abnormal leukocytes are distinguishable from normal leukocytes on the basis of light-scatter properties, a low level of CD45 expression, and heterogeneous CD117 expression.
Read More »Calibrator, control for hematology system, 4/13:88
Streck’s CVA, an assayed linearity control kit used to determine the patient reportable range of three- and five-part hematology instruments, is now assayed for Beckman Coulter’s UniCel DxH 800. CVA establishes an instrument’s reportable range and verifies linearity, testing the instrument’s extreme upper and lower limits, ensuring that patient results are valid.
Read More »HbA1c control assay, 3/13
Streck’s A1c-Cellular HbA1c control with intact red blood cells is now assayed for Roche Diagnostics’ Cobas c311. A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell. This step ensures that the entire system—instrument and reagents—is working properly and providing accurate patient results. The control is easy to use; it does not require reconstitution, which reduces the potential for human error.
Read More »Lamellar body count control for hematology instruments, 2/13:109
Streck’s LBC-Chex is a lamellar body count control. Lamellar bodies have been analyzed as an indirect estimate of fetal lung maturity and potential indicator of respiratory distress syndrome.
Read More »